Treating chronically ill people with diabetes mellitus with limited life expectancy: Implications for performance measurement

Journal of the American Geriatrics Society

Volumn 60, Issue 2, 2012, Pages 193-201

  Woodard, Lechauncy D ^a,b   Landrum, Cassie R ^a   Urech, Tracy H ^a   Profit, Jochen ^a,b   Virani, Salim S ^a,b   Petersen, Laura A ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

diabetes mellitus; limited life expectancy; performance measurement; quality of care

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; AGING; ALGORITHM; ARTICLE; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEMENTIA; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; HUMAN; LIFE EXPECTANCY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; PRIMARY TUMOR;

EID: 84856835102     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03784.x     Document Type: Article

References (37)

1. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005; 294: 716-724. (Pubitemid 41159291)
2. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus. J Am Geriatr Soc 2003; 51 (5 Suppl Guidelines): S265-S280.
3. Veterans Health Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Diabetes Mellitus. Version 4.0. Release date: August 2010.
4. Office of Quality and Performance. FY 2011 Q1 Clinical Measures Specification Manual, 2. Veterans Health Administration. October 1, 2010.
5. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. JAMA 2003; 290: 2581-2587. (Pubitemid 37443288)
6. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute. Available at Accessed July 26, 2011.
7. Hayward RA,. Performance measurement in search of a path. N Engl J Med 2007; 346: 951-952.
8. Solberg LI, Engebretson KI, Sperl-Hillen JM, et al. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual 2006; 21: 238-245. (Pubitemid 44035782)
9. Silveira MJ, Kazanis AS, Shevrin MP,. Statins in the last six months of life: A recognizable, life-limiting condition does not decrease their use. J Palliat Med 2008; 11: 685-693. (Pubitemid 351918845)
10. Braun UK, McCollough LB, Beyth RJ, et al. Racial and ethnic differences in the treatment of seriously ill patients: A comparison of African-American, Caucasian and Hispanic veterans. J Natl Med Assoc 2008; 100: 041-1051.
11. Casarett DJ, Quill TE,. "I'm not ready for hospice": Strategies for timely and effective hospice discussions. Ann Intern Med 2007; 146: 443-449. (Pubitemid 351650577)
12. Fox E, Landrum-McNiff K, Zhong Z, et al. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA 1999; 282: 1638-1645. (Pubitemid 29513970)
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
14. Goddihn PP, Bilo HJ, Feskens EJ, et al. Longitudinal study on glycemic control and quality of life in patients with type 2 diabetes mellitus referred for intensified control. Diabet Med 1999; 16: 23-30. (Pubitemid 29147219)
15. Shorr RI, Franse LV, Resnick He, et al. Glycemic control of older adults with type 2 diabetes: Findings from the Third National Health and Nutrition Examination Survey, 1988-94. J Am Geriatr Soc 2000; 48: 264-267. (Pubitemid 30164208)
16. Office of Quality and Performance. FY 2007, Q3 Technical Manual. VHA Performance Measurement System. Office of Quality and Performance. March 16, 2007.
17. Petersen LA, Pietz K, Woodard LD, et al. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care 2005; 43: 61-67. (Pubitemid 40137615)
18. Petersen LA, Byrne MM, Daw CN, et al. Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled veterans. Health Serv Res 2010; 45: 762-791.
19. Rabe-Hesketh S, Skrondal A, Pickles A,. GLLAMM Manual, Paper 160. Berkley, CA: University of California, 2004.
20. McEwen LN, Bilik D, Johnson SL, et al. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes. Diabetes Care 2009; 32: 971-976.
21. Ko DT, Mamdani M, Alter DA,. Lipid-lowering therapy with statins in high-risk elderly patients: The treatment-risk paradox. JAMA 2004; 291: 1864-1870. (Pubitemid 38509499)
22. Virani SS, Woodard LD, Chitwood SS, et al. Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease. Am Heart J 2011; 162: 725-732.
23. British Medical Association. Quality and outcomes framework guidance: Section 2: Clinical indicators [on-line]. Available at Accessed July 26, 2011.
24. Doran T, Fullwood C, Reeves D, et al. Exclusion of patients from pay-for-performance targets by English physicians. N Engl J Med 2008; 359: 274-284. (Pubitemid 352008442)
25. McDonald R, Rolan M,. Pay for performance in primary care in England and California: Comparison of unintended consequences. Ann Fam Med 2009; 7: 121-127.
26. Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: A decision analysis. Ann Intern Med 2008; 149: 11-19.
27. Bayliss EA, Edwards AE, Steiner JF, et al. Processes of care desired by elderly patients with multimorbidities. Fam Pract 2008; 25: 287-293.
28. Choe HM, Bernstein SJ, Standiford CJ, et al. New diabetes HEDIS blood pressure quality measure: Potential for overtreatment. Am J Manag Care 2010; 16: 19-24.
29. Wegner MS, Solomon DH, Amin A, et al. Application of Assessing Care of Vulnerable Elders-3 quality indicators to patients with advanced dementia and poor prognosis. J Am Geriatr Soc 2007; 55 (Suppl 2): S457-S463. (Pubitemid 47512157)
30. Weiner JS, Roth J,. Avoiding iatrogenic harm to patient and family while discussing goals of care near the end of life. J Palliat Med 2006; 9: 451-463.
31. Larson DG, Tobin DR,. End-of-life conversations: Evolving practice and theory. JAMA 2000; 284: 1573-1578.
32. Curtis JR, Patrick DL, Caldwell ES, et al. Why don't patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med 2000; 160: 1690-1696. (Pubitemid 30367909)
33. Christakis NA, Lamont EB,. Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ 2000; 320: 469-473.
34. Executive Summary. American Diabetes Association. Standards of Medical Care in Diabetes-2009. Diabetes Care 2009; 32 (Suppl 1): S6-S12.
35. Kerr EA, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: The TRIAD Study. Ann Intern Med 2004; 141: 272-281.
36. Asch SM, McGlynn EA, Hogan MM, et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 2004; 141: 938-945.
37. Walter LC, Davidowtiz NO, Heineken PA, et al. Pitfalls of converting practice guidelines into quality measures: Lessons learned from a VA performance measure. JAMA 2004; 291: 2466-2470. (Pubitemid 38669190)